“I feel like I’m a person who goes with the flow,” said Suhasni Gopalakrishnan, Director at Allogene Therapeutics in San Francisco. Going with the flow has led Gopalakrishnan to many fascinating places. …
For physician-scientist Noah Merin, the form of stem cell transplantation known as bone marrow transplantation remains the “coolest thing in medicine” and the focus of his career. “I do bone marrow transplantation …
To accelerate stem cell treatments to patients with unmet medical needs, the California Institute for Regenerative Medicine (CIRM) has always recognized the need to educate and train a scientific workforce. Since 2006, …
Aimed at identifying and nurturing scientific talent, the scholarships support students focused on developmental biology and pediatric neurology. The Goldwater scholarships, administered by the Barry Goldwater Scholarship and Excellence in Education Foundation, …
To stimulate interdisciplinary and creative trainee-directed stem cell research Overview USC Stem Cell invites applications for the Broad Collaborative Challenge Grant for Graduate Students and Postdoctoral Fellows. The goal of the program …
The Chung Lab has engineered a new therapeutically enhanced, naturally derived particle for powerful gene therapies to tackle our most significant health challenges. Cardiovascular disease and kidney disease are two of the …
Experts in engineering, gerontology and stem cell research will collaborate to find treatments for age-related conditions like osteoarthritis and cardiovascular disease. Keck School of Medicine of USC will launch a new research …
Alfred E. Mann Department of Biomedical Engineering graduating senior Alex Kuncz is studying how lizards regenerate their tails to improve orthopedic treatments. USC Viterbi graduating BME senior Alex Kuncz wants to help …
After starting with Minecraft mods at 13, Joey Yap now applies his skills in signal processing to pediatric brain data and is headed to NYU for a Ph.D. in biomedical engineering. This …
In research led by the Keck School of Medicine of USC, the new drug candidate selectively attacked glioblastoma stem cells and passed early safety testing in a phase 1 clinical trial. A …